Examination of potential mechanisms to explain the association between proton pump inhibitors and Clostridium difficile infection.
Proton pump inhibitors (PPIs) have been associated with Clostridium difficile infection (CDI) in several recent studies. However, other studies have not shown this association, and the mechanism by which PPIs might promote CDI has not been elucidated. We hypothesized two possible mechanisms of causation: first, by raising pH, PPIs may prevent gastric contents from killing C. difficile spores; second, gastric contents of PPI-treated patients may promote germination and outgrowth of C. difficile spores. Survival rates of spores from six different strains of C. difficile in acidic gastric contents were assessed using quantitative cultures on selective media. Germination and outgrowth of spores were assessed by heat shock at 80 degrees C, phase-contrast microscopy, and ethanol shock after incubation for 24 h in the gastric contents of patients and in the gastric, small intestinal, and cecal contents of mice. C. difficile spores survived and remained dormant in nonbilious gastric contents with acidic pH. Germination did not occur in unmodified gastric contents of patients but did occur with the addition of taurocholic acid and amino acids. In mice, germination did not occur in gastric contents but did occur in small intestinal and cecal contents. In summary, C. difficile spores survived in acidic gastric contents and did not undergo germination and outgrowth in gastric contents, probably due to lack of essential germinants, such as taurocholic acid. Our results suggest that the effects of PPIs in the stomach do not contribute to the pathogenesis of CDI.
Nerandzic
Michelle M
MM
Research Service, Louis Stokes Cleveland Veterans Affairs Medical Center, Cleveland, OH 44106, USA.
Pultz
Michael J
MJ
Donskey
Curtis J
CJ
D000818:Animals; D000900:Anti-Bacterial Agents / Q000627:therapeutic use*; D002432:Cecum / Q000382:microbiology; D016360:Clostridioides difficile / Q000187:drug effects* / Q000502:physiology*; D003015:Clostridium Infections / Q000188:drug therapy* / Q000382:microbiology; D005260:Female; D006801:Humans; D006863:Hydrogen-Ion Concentration; D007422:Intestines / Q000382:microbiology; D051379:Mice; D054328:Proton Pump Inhibitors / Q000494:pharmacology / Q000627:therapeutic use*; D013171:Spores, Bacterial / Q000187:drug effects; D013270:Stomach / Q000382:microbiology
D000900:Anti-Bacterial Agents; D054328:Proton Pump Inhibitors